Physician Assistant, Medical · Tulsa, OK
NPI
1013994458
Since 2005
Specialty
Physician Assistant, Medical
Code 363AM0700X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
6565 S Yale Ave Ste 1200
Tulsa, OK, 74136
Phone (918) 502-3376
Groups this clinician bills Medicare through
Medicare paid, 2024
$141K
3,529 services
Medicare patients, 2024
787
Average age 73
Drug cost, 2024
$1.5M
1,531 prescriptions
Company payments, 2025
$6,639
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Tara Linville was code 17003 (destruction skin lesion), 1,092 times for 183 patients. In total Tara Linville billed 3,529 services in 63 codes, and Medicare paid $141K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-05-14.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 17003 Destruction Skin Lesion | Office | 1,092 | 183 | $3.74 | $4,085 |
| 99213 Office E&M - Established | Office | 780 | 534 | $49.94 | $39K |
| 17110 Destruction Skin Lesion | Office | 369 | 308 | $56.04 | $21K |
| 17000 Destruction Skin Lesion | Office | 297 | 223 | $28.19 | $8,371 |
| 99214 Office E&M - Established | Office | 210 | 140 | $64.55 | $14K |
| 99203 Office E&M - New | Office | 164 | 164 | $57.09 | $9,363 |
| 11106 Skin Biopsy | Office | 122 | 113 | $83.15 | $10K |
| 17111 Destruction Skin Lesion | Office | 99 | 72 | $65.78 | $6,512 |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 68 | 18 | $0.63 | $42.85 |
| 17004 Destruction Skin Lesion | Office | 41 | 28 | $86.25 | $3,536 |
| 99204 Office E&M - New | Office | 39 | 39 | $91.92 | $3,585 |
| 11107 Skin Biopsy | Office | 18 | 14 | $43.52 | $783 |
| 13121 Wound Repair - All Levels | Office | 17 | 16 | $259.81 | $4,417 |
| 11603 Skin Lesion Excision | Office | 17 | 16 | $85.86 | $1,460 |
| 11900 Skin | Office | 14 | 13 | $25.70 | $360 |
By year: 2022 $120K for 2,849 services; 2023 $137K for 3,306 services; 2024 $141K for 3,529 services.
Medicare prescription drug claims, 2024
In 2024, the drug Tara Linville prescribed most often to Medicare patients was Ketoconazole, with 203 prescriptions and refills. In total Tara Linville wrote 1,531 Medicare prescriptions that cost $1.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ketoconazole Generic | 203 | 214 | 98 | $3,019 |
| Triamcinolone Acetonide Generic | 199 | 252 | 131 | $3,741 |
| Clobetasol Propionate Generic | 123 | 130 | 62 | $7,617 |
| Doxycycline Hyclate Generic | 78 | 133 | 40 | $1,917 |
| Betamethasone Dipropionate Generic | 70 | 70 | 43 | $3,596 |
| Doxepin Hcl Generic | 64 | 97 | 22 | $1,552 |
| Hydrocortisone Generic | 53 | 60 | 39 | $835 |
| Fluorouracil Generic | 48 | 57 | 43 | $4,223 |
| Dupixent Pen Dupilumab | 47 | 48 | Under 11 | $194K |
| Minocycline Hcl Generic | 47 | 79 | 27 | $1,198 |
| Hydroxyzine Hcl Generic | 40 | 45 | 14 | $511 |
| Spironolactone Generic | 38 | 61 | Under 11 | $510 |
| Metronidazole Generic | 34 | 35 | 23 | $1,619 |
| Otezla Apremilast | 28 | 28 | Under 11 | $144K |
| Prednisone Generic | 27 | 29 | 17 | $73.58 |
Brand drugs: 228 claims; generic drugs: 1,303 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Tara Linville $6,639 ($6,639 in general payments such as food, travel and fees) from 19 companies. The largest payer was Janssen Biotech, Inc. with $779.
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. JNJ | 26 | $779 |
| Pfizer Inc. PFE | 35 | $773 |
| Abbvie Inc. ABBV | 24 | $681 |
| Amgen Inc. AMGN | 20 | $533 |
| UCB, Inc. UCB.BR | 40 | $530 |
| Regeneron Healthcare Solutions, Inc. REGN | 16 | $523 |
| Arcutis Biotherapeutics, Inc. ARQT | 26 | $522 |
| Novartis Pharmaceuticals Corporation NVS | 23 | $486 |
| Lilly USA, LLC LLY | 15 | $378 |
| E.R. Squibb & Sons, L.L.C. BMY | 19 | $284 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.